"Leukemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Descriptor ID |
D007938
|
| MeSH Number(s) |
C04.557.337
|
| Concept/Terms |
Leukemia- Leukemia
- Leukemias
- Leucocythaemia
- Leucocythaemias
- Leucocythemia
- Leucocythemias
|
Below are MeSH descriptors whose meaning is more general than "Leukemia".
Below are MeSH descriptors whose meaning is more specific than "Leukemia".
This graph shows the total number of publications written about "Leukemia" by people in this website by year, and whether "Leukemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 3 | 0 | 3 |
| 2008 | 1 | 0 | 1 |
| 2012 | 1 | 2 | 3 |
| 2013 | 2 | 2 | 4 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 29 | 10 | 39 |
| 2018 | 23 | 10 | 33 |
| 2019 | 12 | 3 | 15 |
| 2020 | 4 | 3 | 7 |
| 2021 | 2 | 2 | 4 |
| 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Leukemia" by people in Profiles.
-
The Status of Pediatric Patients With Hematologic Malignancy During COVID-19 Pandemic in Wuhan City, China. J Pediatr Hematol Oncol. 2022 01 01; 44(1):e127-e133.
-
Acute leukemia and SARS-CoV-2 infection: clinical characteristics and risk factors for mortality. Leuk Lymphoma. 2021 12; 62(14):3516-3520.
-
The Care of the Leukemic Patients in Times of SARS-CoV-2. Curr Oncol Rep. 2021 08 03; 23(10):114.
-
Monoclonal antibodies for the treatment of COVID-19 in a patient with high-risk acute leukaemia. Br J Haematol. 2022 01; 196(1):e1-e3.
-
A Survey of Parents on the Effects of COVID-19 Pandemic on Children Receiving Antileukemic Therapy. J Pediatr Hematol Oncol. 2021 07 01; 43(5):e740-e741.
-
Varicella-Zoster virus reactivation following SARS-CoV-2 immunization in two patients with leukemia. Pediatr Blood Cancer. 2021 10; 68(10):e29191.
-
COVID-19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience. Br J Haematol. 2021 08; 194(4):e74-e77.
-
Leukemic presentation with discordant morphology in triple-hit lymphoma-A diagnostic pitfall during COVID-19 pandemic. Int J Lab Hematol. 2021 12; 43(6):e300-e302.
-
Swarm Learning for decentralized and confidential clinical machine learning. Nature. 2021 06; 594(7862):265-270.
-
How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic? Diabetes. 2021 05; 70(5):1021-1028.